Related Experiment Video

Updated: Jun 21, 2025

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.7K

Cost-utility and actionability of genomic sequencing for inflammatory linear verrucous epidermal nevus

James P Pham1, Deshan F Sebaratnam1

  • 1Department of Dermatology, Liverpool Hospital, Liverpool, New South Wales, Australia; School of Clinical Medicine, University of New South Wales Medicine and Health, Sydney, New South Wales, Australia.

Journal of the American Academy of Dermatology
|July 11, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ILVENcost-utilitygenomic analysisinflammatory linear epidermal nevusnext-generation sequencing

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.6K